AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Development of Ling-zhi industry in China – emanated from the artificial cultivation in the Institute of Microbiology, Chinese Academy of Sciences (IMCAS)

Saifei LiCaihong DongHua’an Wen( )Xingzhong Liu( )
State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Show Author Information

Abstract

Ling-zhi is a medicinal herb that generally refers to a fungus in the genus Ganoderma. It has been used as a medicinal mushroom in traditional Chinese medicine for more than 2000 years. Mycologists at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS) first artificially cultivated the Ling-zhi fruiting body in the late 1960s (X.J. Liu’s team). In IMCAS, different research teams have extensively studied Ling-zhi in the aspects of national resource surveys, systematic taxonomy, chemical analysis, and processing for medicinal and health applications. The research results from IMCAS have provided essential support and prompted the development of the Ling-zhi industry in China to some extent. This review aims to summarize the history of research on Ling-zhi in IMCAS and its role in the development of the Ling-zhi economy.

References

 
Anonymous. (102–200AD, reprinted in 1955). Shen Nong Materia Medica. Beijing: People’s Hygiene Press. Chinese.
 

Anonymous. 1971. Cultivation of ‘Ling-zhi’. Season 2, compilation of microbial data. Beijing: Science Press; p. 51–60. Chinese.

 

Anonymous. 1992. Record of earliest cultivation of ‘Ling-zhi’. Microbiol Bull 19:189–193. Chinese.

 

Cao Y, Wu S-H, Dai Y-C. 2012. Species clarification of the prize medicinal Ganoderma mushroom “Lingzhi”. Fungal Divers. 56:49–62.

 

Chang M-Y, Tsai G-J, Houng J-Y. 2006. Optimization of the medium composition for the submerged culture of Ganoderma lucidum by Taguchi array design and steepest ascent method. Enzyme Microb Technol. 38:407–414.

 

Chang ST. 2004. Ganoderma lucidum–a leader of edible and medicinal mushrooms. Int Agri Trade. 90:22–24.

 

Chen H, Yang HL, Liu GQ. 2015. Biosynthesis and fermentation control of triterpenoids from Ganoderma lingzhi. Mycosystema. 34:1–9.

 

[CPC] China Pharmacopoeia Committee. 2000. Pharmacopoeia of People’s Republic of China 2000 edition (Part one). Beijing: Chemical Industry Press. Chinese.

 

Fatmawati S, Kondo R, Shimizu K. 2013. Structure–activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. Bioorg Med Chem Lett. 23:5900–5903.

 

Gao YJ, Yuan B, Yang WJ, Fang Y, Ma N, Hu QH. 2014. Preparation of Ganoderma lingzhi spore oil microcapsules. Mycosystema. 33:483–492.

 

Guan MC, Tang WH, Xu Z, Sun J. 2014. Effects of Selenium-Enriched Protein from Ganoderma lucidum on the Levels of IL-1β and TNF-α, Oxidative Stress, and NF-κB Activation in Ovalbumin-Induced Asthmatic Mice. Evid-Based Compl Alt. 2014:1–6.

 

Huang SZ, Cheng BH, Ma QY, Wang Q, Kong FD, Dai HF, Qiu SQ, Zheng PY, Liu ZQ, Zhao Y-X. 2016. Anti-allergic prenylated hydroquinones and alkaloids from the fruiting body of Ganoderma calidophilum. RSC Adv. 6:21139–21147.

 

Ko H-H, Hung C-F, Wang J-P, Lin C-N. 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry. 69:234–239.

 

Lai T, Gao Y, Zhou SF. 2004. Global marketing of medicinal Ling Zhi mushroom Ganoderma lucidum (W.Curt.: Fr.)Lloyd (Aphyllophoromycetideae) products and safety concerns. Int J Med Mushrooms. 6:189–194.

 

Li KK, Zhang CM, Gu HD, Jin Y, Qu JJ. 2014. Optimization of Ganoderma lingzhi S3 fermentation medium and inhibition of the fermented liquid against Fusarium oxysporum. Mycosystema. 33:401–410.

 

Li T-H, Hu H-P, Deng W-Q, Wu S-H, Wang D-M, Tsering T. 2015. Ganoderma leucocontextum, a new member of the G. lucidum complex from southwestern China. Mycoscience. 56:81–85.

 

Lin HJ, Chang YS, Lin LH, Haung CF, Wu CY, Ou KL. 2014. An immunomodulatory protein (Ling Zhi-8) from a Ganoderma lucidum induced acceleration of wound healing in rat liver tissues after Monopolar Electrosurgery. Evid-Based Compl Alt. 2014:1–12.

 

Lin ZB. 2005. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmcol Sci. 99:144–153.

 

Ma K, Li L, Bao L, He LW, Sun C, Zhou B, Si SY, Liu HW. 2015. Six new 3,4-seco-27-norlanostane triterpenes from the medicinal mushroom Ganoderma boninense and their antiplasmodial activity and agonistic activity to LXRβ. Tetrahedron. 71:1808–1814.

 

Mao XL. 1998. Economic fungi of China. Beijing: Science Press. Chinese.

 

Mao XL. 2000. The Macrofungi in China. Zhengzhou: He’nan Science Press. Chinese.

 

Mao XL. 2009. Mushroom China. Beijing: Science Press. Chinese.

 

Patouillard N. 1907. Champignons du Kouy-tcheou. Monde. d. be. Pl. Seri. 2:31.

 

Peng XR, Liu JQ, Xia JJ, Wang CF, Li XY, Deng YY, Bao NM, Zhang ZR, Qiu MH. 2015. Lanostane triterpenoids from Ganoderma hainanense J. D. Zhao. Phytochemistry. 114:137–145.

 

Pi C-C, Chu C-L, Lu C-Y, Zhuang Y-J, Wang C-L, Yu Y-H, Wang H-Y, Lin C-C, Chen C-J. 2014. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo. Vaccine. 32:401–408.

 

Seo HW, Hung TM, Na MK, Jung HJ, Kim JC, Choi JS, Kim JH, Lee H-K, Lee IS, Bae KH, et al. 2009. Steroids and Triterpenes from the Fruit Bodies of Ganoderma lucidum and their Anti-complement Activity. Arch Pharm Res. 32:1573–1579.

 

Smina TP, Joseph J, Janardhanan KK. 2016. Ganoderma lucidum total triterpenes prevent γ-radiation induced oxidative stress in Swiss albino mice in vivo. Redox Rep. 21:1–8.

 

Tai FL. 1979. Sylloge Fungorum Sinicorum. Beijing: Science Press. Chinese.

 

Tang Y-J, Zhang W, Liu R-S, Zhu L-W, Zhong J-J. 2011. Scale-up study on the fed-batch fermentation of Ganoderma lucidum for the hyperproduction of ganoderic acid and Ganoderma polysaccharides. Process Biochem. 46:404–408.

 

Tang Y-J, Zhong J-J. 2003. Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enzyme Microb Tech. 32:478–484.

 

Teng SC. 1934. Notes on polyporaceae from China. Sinensia. 5:173–224.

 

Teng SC. 1963. Fungi of China. Beijing: Science Press; p. 439–454. Chinese.

 

Wang DM, Yao YJ. 2005. Intrastrain internal transcribed spacer heterogeneity in Ganoderma species. Can J Microbiol. 51:113–121.

 

Wang JY, Wang CG, Zhang JS, Zhu LN, Liu YF, Zhou S, Zhang Z, Tang QJ. 2016. An analysis on nucleosides of spore powder produced by Ganoderma lingzhi. Mycosystema. 35:77–85.

 

Wang K, Bao L, Xiong WP, Ma K, Han JJ, Wang WZ, Yin WB, Liu HW. 2015. Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and their inhibitory effects on HMG-CoA Reductase and α-Glucosidase. J Nat Prod. 78:1977–1989.

 
Wang XC. 2012. Phylogenetic study on Ganodermataceae Donk [doctoral dissertation]. Unpublished.
 

Wang XC, Xi RJ, Li Y, Wang DM, Yao YJ. 2012. The Species identity of the widely cultivated Ganoderma, ‘G. lucidum’ (Ling-zhi), in China. PloS One. 7:1–10.

 

Wu XL, Song B, Zhao YX, Wen TC, Huang SZ, Lin M. 2013. Study on Medicinal Ganoderma in China and Discussion about Name Use of Ganoderma spp. Guizhou Sci. 31:1–17. Chinese.

 

Xu P, Ding Z-Y, Qian Z, Zhao C-X, Zhang K-C. 2008. Improved production of mycelial biomass and ganoderic acid by submerged culture of Ganoderma lucidum SB97 using complex media. Enzyme Microb Tech. 42:325–331.

 

Yan Y-M, Wang X-L, Luo Q, Jiang L-P, Yang C-P, Hou B, Zuo Z-L, Chen Y-B, Cheng Y-X. 2015. Metabolites from the mushroom Ganoderma lingzhi as stimulators of neural stem cell proliferation. Phytochemistry. 114:155–162.

 

Yang ZL, Feng B. 2013. What is the Chinese “Lingzhi”? – a taxonomic mini-review. Mycology. 4:1–4.

 

Ying JZ, Mao XL, Ma QM, Zong YC, Wen HA. 1987. Icones of medicinal fungi from China. Beijing: Science Press. Chinese.

 

Zhang S, Nie S, Huang D, Feng Y, Xie M. 2014. A novel polysaccharide from Ganoderma atrum exerts antitumor activity by activating mitochondria-mediated apoptotic pathway and boosting the immune system. J Agr Food Chem. 62:1581–1589.

 

Zhang WJ, Tao YJ, Yang XP, Yang ZL, Zhang L, Liu HS, Wu KL, Wu JG. 2014. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem Bioph Res Co. 449:307–312.

 

Zhang XQ. 1997. Four new records of Ganodermataceae from China. Mycosystema. 16:259–263. Chinese.

 

Zhang XQ. 1998. Six New Records of Polyporaceae and Ganodermataceae in China. J Jilin Agric Univ. 20:205. Chinese.

 

Zhao JD. 1987. Studies on the taxonomy of Ganodermataceae in China. X. Subgen. Ganoderma sect. Phaeonema. Acta Mycol Sinica. 7:205–211. Chinese.

 

Zhao JD. 1988a. Studies on the taxonomy of Ganodermataceae in China. Ⅸ. Subgenus Elfvingia (Karst.) Imazeki. Acta Mycol Sinica. 7:13–22. Chinese.

 

Zhao JD. 1988b. Studies on the taxonomy of Ganodermataceae in China. Ⅸ. Subgen. Ganoderma sect. Ganoderma. Acta Mycol Sinica. 8:25–34. Chinese.

 

Zhao JD. 1989. New ‘Ling-zhi’ of China. Beijing: Science Press. Chinese.

 

Zhao JD, Xu LW, Zhang XQ. 1979. Taxonomic studies on the subfamily Ganodermataceae of China Ⅲ. Acta Mycol Sinica. 19:265–279. Chinese.

 

Zhao JD, Xu LW, Zhang XQ. 1981. ‘Ling-zhi’ of China. Beijing: Science Press. (in Chinese)

 

Zhao JD, Xu LW, Zhang XQ. 1983. Taxonomic studies on the family Ganodermataceae of China Ⅱ. Acta Mycol Sinica. 2:159–167. Chinese.

 

Zhao JD, Xu LW, Zhang XQ. 1984. Studies on the taxonomy of Ganodermataceae in China Ⅲ. Acta Mycol Sinica. 3:15–23. Chinese.

 

Zhao JD, Zhang XQ. 1986. Studies on the taxonomy of Ganodermataceae in China Ⅴ. Acta Mycol Sinica. 5:219–225. Chinese.

 

Zhao JD, Zhang XQ. 1987a. Studies on the taxonomy of Ganodermataceae in China. Ⅷ. Additional report of eight revisionary species and three new species. Acta Mycol Sinica. 6:199–210. Chinese.

 

Zhao JD, Zhang XQ. 1987b. Studies on the taxonomy of Ganodermataceae in China Ⅵ. Acta Mycol Sinica. 6:1–7. Chinese.

 

Zhao JD, Zhang XQ. 1992. Resource and distribution of Ganodermataceae in China. Acta Mycol Sinica. 11:55–62. Chinese.

 

Zhao JD, Zhang XQ. 2000. Flora Fungorum Sinicorum 18: Ganodermataceae. Beijing: Science Press. Chinese.

 

Zhao JD, Zhang XQ, Xu LW. 1986. Studies on the taxonomy of Ganodermataceae in China Ⅳ. Acta Mycol Sinica. 5:86–93. Chinese.

 

Zhao Z-Z, Chen H-P, Feng T, Li Z-H, Dong Z-J, Liu J-K. 2015. Lucidimine AD, four new alkaloids from the fruiting bodies of Ganoderma lucidum. J Asian Nat Prod Res. 17:1160–1165.

 

Zhou L-W, Cao Y, Wu S-H, Vlasák J, Li D-W, Li M-J, Dai Y-C. 2015. Global diversity of the Ganoderma lucidum complex (Ganodermataceae, Polyporales) inferred from morphology and multilocus phylogeny. Phytochemistry. 114:7–15.

 

Zhu K-X, Nie S-P, Tan L, Li C, Gong D, Xie M-Y. 2016. A polysaccharide from Ganoderma atrum improves liver function in type 2 diabetic rats via antioxidant action and short-chain fatty acids excretion. J Agr Food Chem. 64:1938–1944.

Mycology
Pages 74-80
Cite this article:
Li S, Dong C, Wen H, et al. Development of Ling-zhi industry in China – emanated from the artificial cultivation in the Institute of Microbiology, Chinese Academy of Sciences (IMCAS). Mycology, 2016, 7(2): 74-80. https://doi.org/10.1080/21501203.2016.1171805

149

Views

16

Crossref

0

Web of Science

23

Scopus

Altmetrics

Received: 03 February 2016
Accepted: 23 March 2016
Published: 28 April 2016
© 2016 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return